Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion, Johns Hopkins to Continue Collaboration on Cancer Biomarkers

NEW YORK (GenomeWeb News) – Vermillion today said that it has renewed a long-standing collaboration with Johns Hopkins University to develop biomarkers that can be potentially used as molecular diagnostics for cancer.
Under the terms of the agreement, Vermillion will have access to exclusive commercial rights to any discoveries from the partnership. Other terms of the alliance were not disclosed.
Vermillion will supply its technology platforms and fund research efforts, while Johns Hopkins will supply cancer serum samples along with the expertise of its physicians and scientists.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.